ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that executive management will present at the following investor conferences in May 2011:

• The Deutsche Bank 36th Annual Health Care Conference in Boston. Jan Keltjens, President and Chief Executive Officer, is scheduled to present an overview of the Company on Monday, May 2, 2011, at 3:30 p.m. ET.
• Bank of America Merrill Lynch Health Care Conference in Las Vegas. Mr. Keltjens is scheduled to present an overview of the Company on Tuesday, May 10, 2011, at 4:20 p.m. PT.

To listen to the audio web cast of a presentation during or after the event, please visit: http://investors.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Gregory Gin, 415-896-6820 (Investor Relations)
ggin@evcgroup.com
or
EVC Group, Inc.
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com

Source: AngioDynamics, Inc.

News Provided by Acquire Media